search
Back to results

The Effect of Midazolam on Fluid Responsiveness in Septic Patients

Primary Purpose

Septic Shock

Status
Completed
Phase
Phase 1
Locations
China
Study Type
Interventional
Intervention
sedatives(Midazolam and Propofol)
Sponsored by
Southeast University, China
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Septic Shock focused on measuring septic shock, sepsis, fluid responsiveness, Midazolam, Propofol, haemodynamics

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Patients are included if they meet the following inclusion criteria:

  1. Above 18 years old
  2. Endotracheal intubated and mechanical ventilated
  3. Awake, can communicate with researchers
  4. Diagnosed as septic shock. The definition of septic shock was clarified in Year 2001 ACCP/SCCM guidelines
  5. Within 24 hours after the EGDT resuscitation goals are achieved
  6. Informed consent are signed.

Exclusion Criteria

  1. Under 18 years old
  2. Intra-abdominal hypertension
  3. Central nerves system dysfunction
  4. Heart failure and other cardiac dysfunction such as cardiac conduction block,acute coronary syndrome, cardiogenic shock
  5. Proof of volume overload or contradiction of fluid infusion
  6. Existence of arterial aneurysm, serious valvular disease,extensive peripheral vascular occlusion disease and insertion of artificial pacemaker

Sites / Locations

  • Department of Critical Care , Zhong-da Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Midazolam

Propofol

Arm Description

Midazolam infused at a 0.03mg/kg loading dose ,and 0.02-0.1mg/kg.h maintenance dose to achieve Ramsay score of 4

Propofol infuse at a loading dose of 0.5mg/kg,and 0.5-2.0mg/kg.h maintenance dose to achieve Ramsay score of 4

Outcomes

Primary Outcome Measures

percentage of participants with more than 10% increase of cardiac index by passive leg raising after sedation

Secondary Outcome Measures

Full Information

First Posted
March 5, 2013
Last Updated
January 30, 2014
Sponsor
Southeast University, China
search

1. Study Identification

Unique Protocol Identification Number
NCT02050893
Brief Title
The Effect of Midazolam on Fluid Responsiveness in Septic Patients
Study Type
Interventional

2. Study Status

Record Verification Date
January 2014
Overall Recruitment Status
Completed
Study Start Date
May 2012 (undefined)
Primary Completion Date
April 2013 (Actual)
Study Completion Date
April 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Southeast University, China

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Fluid resuscitation remains the foundation for septic treatment.The evaluation of fluid responsiveness has significance in volume resuscitation for septic shock patients. As the sedative which is commonly used in ICU, Midazolam is supposed to change fluid responsiveness for the pharmacological effect of venodilation. However, the hypothesis has not been certified clinically. In this research, the investigators aim to test the hypothesis that Midazolam can increase fluid responsiveness(using passive leg raising test) in septic shock patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Septic Shock
Keywords
septic shock, sepsis, fluid responsiveness, Midazolam, Propofol, haemodynamics

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Midazolam
Arm Type
Experimental
Arm Description
Midazolam infused at a 0.03mg/kg loading dose ,and 0.02-0.1mg/kg.h maintenance dose to achieve Ramsay score of 4
Arm Title
Propofol
Arm Type
Experimental
Arm Description
Propofol infuse at a loading dose of 0.5mg/kg,and 0.5-2.0mg/kg.h maintenance dose to achieve Ramsay score of 4
Intervention Type
Drug
Intervention Name(s)
sedatives(Midazolam and Propofol)
Primary Outcome Measure Information:
Title
percentage of participants with more than 10% increase of cardiac index by passive leg raising after sedation
Time Frame
Baseline,after sedation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Patients are included if they meet the following inclusion criteria: Above 18 years old Endotracheal intubated and mechanical ventilated Awake, can communicate with researchers Diagnosed as septic shock. The definition of septic shock was clarified in Year 2001 ACCP/SCCM guidelines Within 24 hours after the EGDT resuscitation goals are achieved Informed consent are signed. Exclusion Criteria Under 18 years old Intra-abdominal hypertension Central nerves system dysfunction Heart failure and other cardiac dysfunction such as cardiac conduction block,acute coronary syndrome, cardiogenic shock Proof of volume overload or contradiction of fluid infusion Existence of arterial aneurysm, serious valvular disease,extensive peripheral vascular occlusion disease and insertion of artificial pacemaker
Facility Information:
Facility Name
Department of Critical Care , Zhong-da Hospital
City
Nanjing
State/Province
Jiangsu
ZIP/Postal Code
(86)210009
Country
China

12. IPD Sharing Statement

Learn more about this trial

The Effect of Midazolam on Fluid Responsiveness in Septic Patients

We'll reach out to this number within 24 hrs